Für diese Kanzlei können nur begrenzte Informationen angezeigt werden. Für die folgenden Kanzleien werden vollständigere Informationen angezeigt:
Noted for its FDA regulatory expertise, the team at Greenberg Traurig LLP is also well-versed in major transactions within the pharmaceutical industry. Co-leading the team from Florida, David Peck is noted for his extensive expertise in M&A, and equity and debt financing mandates, with a strong focus on assisting high-growth corporate clients, while co-head Tricia Asaro works out of the New York office. In Washington DC, Nancy Taylor is a key contact for FDA-related work, while Philadelphia’s Brad Rostolsky acts for a diverse client base of pharmacies, electronic healthcare records providers, and medical device companies. Julie Sullivan is a key member of the Denver team, often advising on fee splitting and Medicare revocation-focused matters.
Legal 500 redaktioneller Kommentar
Referenzen
Unabhängig vom Legal 500-Forschungsteam zusammengestellt.
‘Greenberg has high quality lawyers.’
‘This practice stands out as a beacon of excellence in its field, combining unmatched expertise with a forward-thinking approach that sets it apart from other firms. What truly makes this team unique is their commitment to personalized client service, a hallmark of their success. Every client is treated with the utmost respect and given tailored solutions that reflect a deep understanding of their needs and goals.’
Kernmandanten
- ONO Pharmaceutical Co. Ltd
- OPKO Health, Inc.
Highlight-Mandate
Represented ONO Pharmaceutical Co. in its $2.4bn acquisition of Decipher Pharmaceuticals.
Represented CarePlus ER in the acquisition of two distressed freestanding emergency rooms in Houston, TX.